Zynga Inc (NASDAQ:ZNGA) shares moved down -3.50% in last trading session and ended the day at $2.48. ZNGA Gross Margin is 70.40% and its has a return on assets of -5.10%. Zynga Inc (NASDAQ:ZNGA) quarterly performance is 2.90%.
Zynga Inc (NASDAQ:ZNGA) and Rubicon Project announced that the two companies will bring new SponsoredPLAY immersive ad units to political advertisers in time for the 2016 elections via Rubicon Project’s leading Guaranteed Orders platform.
Treehouse Foods, Inc. (NYSE:THS) ended the last trading day at $72.24. Company weekly volatility is calculated as 2.23% and price to cash ratio as 100.76. Treehouse Foods, Inc. (NYSE:THS) showed a weekly performance of -8.87%.
TreeHouse Foods (NYSE:THS) announced that the required waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) in connection with the Company’s previously announced acquisition of ConAgra Foods’ private brands business. TreeHouse Foods today also announced that it has received an Advance Ruling Certificate from the Competition Bureau Canada per the Canadian Competition Act regarding the proposed acquisition.
On 07 January, Neptune Technologies & Bioressources, Inc. (NASDAQ:NEPT) shares moved down -1.68% and was closed at $0.95. Neptune Technologies & Bioressources, Inc. (NASDAQ:NEPT) year to date (YTD) performance is -10.78%.
Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) announces that it has acquired Montreal based, privately held, Biodroga Inc. for $15 million in a combination of cash and stock. All amounts in Canadian dollars. Biodroga is a leading solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. Their customized product offerings primarily include omega-3’s, along with other essential nutritional ingredients that are used in specialty formulations.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) shares moved up 1.07% in last trading session and ended the day at $12.26. PACB Gross Margin is 42.80% and its has a return on assets of -46.10%. Pacific Biosciences of California, Inc. (NASDAQ:PACB) quarterly performance is 57.18%.
Pacific Biosciences of California, Inc., (NASDAQ:PACB) announced that BGI has ordered its first Sequel System and plans to purchase additional units in order to further integrate SMRT Sequencing into its global service business. This purchase is a continuation of the commitment to SMRT Sequencing BGI made earlier this year with its purchase of the PacBio® RS II Sequencer.
ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) caters to the Healthcare space. Its weekly performance is -17.72%. On the last day of trading company shares ended up at $1.30. ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) distance from 50-day simple moving average (SMA50) is -25.83%.
ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced that it will present at the Biotech Showcase 2016 to be held January 11-13, 2016, at the Parc 55 San Francisco.
Leave a Reply